v3.10.0.1
Condensed Consolidated Interim Statements of Operations and Comprehensive Loss - USD ($)
3 Months Ended 6 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Sales $ 547,085 $ 221,847 $ 1,048,418 $ 309,367
Cost of Sales 384,073 59,825 637,236 89,125
Gross Margin 163,012 162,022 411,182 220,242
Operating expenses        
Sales and marketing 427,325 435,294 969,984 880,817
Research and development 679,049 715,400 1,355,792 1,401,309
General and administrative 931,477 1,505,528 1,910,956 2,133,134
Share-based compensation expense (Note 11) 439,328 762,208 1,034,740 1,013,256
Amortization (Note 4) 69,315 76,985 140,368 169,934
Depreciation (Note 7) 16,626 23,820 34,221 48,372
Total operating expenses 2,563,120 3,519,235 5,446,061 5,646,822
Other (income) expenses        
Foreign exchange (27,872) 15,595 (69,006) 114,156
Accretion expense (Note 8) 1,970,167 74,073 2,104,418 74,073
Fair value adjustment (Note 8) (382,010) 0 (337,923) 0
Gain on mark to market revaluation (Note 10) 0 0 (2,048,697) 0
Other expense 22,712 168,480 60,132 241,068
Total other expenses (income) 1,582,997 258,148 (291,076) 429,297
Net loss and comprehensive loss for the period $ (3,983,105) $ (3,615,361) $ (4,743,803) $ (5,855,877)
Loss per share - basic and diluted $ (1.62) $ (5.33) $ (2.02) $ (8.84)
Loss per share - diluted $ (1.62) $ (5.33) $ (2.02) $ (8.84)
Weighted average number of shares outstanding – basic 2,459,169 678,631 2,351,587 662,237
Weighted average number of shares outstanding – diluted 2,459,169 678,631 2,351,587 662,237

Source